M&A Deal Summary |
|
---|---|
Date | 2019-02-05 |
Target | Tube Hollows International |
Sector | Machinery |
Buyer(s) | Confluent Medical |
Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1991 |
Sector | Medical Products |
Confluent Medical is a contract manufacturer of Nitinol-based and balloon catheter medical devices. Confluent provides a broad range of capabilities including developing and manufacturing components, delivery systems, and finished devices for medical device OEMs in many of the fastest-growing healthcare subsectors, including neurovascular, structural heart, electrophysiology, aortic intervention, peripheral vascular, and ENT. Confluent Medical was founded in 1991 and is based in Scottsdale, Arizona.
DEAL STATS | # |
---|---|
Overall | 6 of 7 |
Sector (Machinery) | 1 of 1 |
Type (Add-on Acquisition) | 6 of 6 |
State (Maine) | 1 of 1 |
Country (United States) | 6 of 6 |
Year (2019) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2018-02-08 |
Corpus Medical
Campbell, California, United States Corpus Medical, Inc. is a provider of high-quality consulting and manufacturing services for the development and commercialization of innovative intervention medical devices. Corpus Medical specializes in catheter technologies, assembly of fully packaged devices and medical implants. Corpus Medical was founded in 2009 and is based in Campbell, California. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2021-05-05 |
Electrospinning
Oxfordshire, United Kingdom Electrospinning offers contract services to design, develop and manufacture nanofiber biomaterials for medical devices and regenerative medicine. Electrospinning uses its expertise and experience to support clients in a range of different therapeutic indications, including the supply of the first electrospun biomaterial to be incorporated into an FDA-approved medical device. Electrospinning was founded in 2010 and is based in Oxfordshire, United Kingdom. |
Buy | - |